SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

FABBRI, Leonardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.346
EU - Europa 850
AS - Asia 775
OC - Oceania 4
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.978
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.343
CN - Cina 444
UA - Ucraina 263
TR - Turchia 171
DE - Germania 148
IT - Italia 108
GB - Regno Unito 96
SE - Svezia 93
SG - Singapore 93
FI - Finlandia 53
VN - Vietnam 21
PL - Polonia 20
ID - Indonesia 19
AT - Austria 14
FR - Francia 14
CZ - Repubblica Ceca 12
IN - India 6
RU - Federazione Russa 6
IR - Iran 4
PT - Portogallo 4
RO - Romania 4
TW - Taiwan 4
AU - Australia 3
BE - Belgio 3
CA - Canada 3
IE - Irlanda 3
KR - Corea 3
NL - Olanda 3
JP - Giappone 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BD - Bangladesh 1
CH - Svizzera 1
DK - Danimarca 1
EU - Europa 1
GR - Grecia 1
HK - Hong Kong 1
IL - Israele 1
MK - Macedonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
RS - Serbia 1
VE - Venezuela 1
Totale 4.978
Salva come PNG Salva come JPEG
Città #
Fairfield 469
Woodbridge 414
Jacksonville 274
Houston 263
Chandler 246
Ashburn 203
Cambridge 172
Wilmington 169
Ann Arbor 150
Seattle 150
Izmir 123
Beijing 92
Nanjing 92
Princeton 87
Singapore 46
Shanghai 44
New York 39
San Diego 38
Boardman 33
Milan 33
Addison 32
Tianjin 29
Hebei 28
Nanchang 26
Shenyang 23
Jiaxing 21
Bremen 20
Dong Ket 20
Warsaw 20
Jakarta 18
Changsha 17
Norwalk 16
San Mateo 15
Vienna 14
Dearborn 12
Washington 12
Redwood City 11
Brno 10
Ferrara 10
Guangzhou 9
Mountain View 9
Ningbo 9
Jinan 8
Philadelphia 8
Taizhou 8
Council Bluffs 7
Falls Church 7
Monmouth Junction 7
Zhengzhou 7
Kunming 6
Orange 6
Augusta 5
Lanzhou 5
London 5
Delebio 4
Hefei 4
Leawood 4
Los Angeles 4
Munich 4
Rome 4
Brussels 3
Dallas 3
Genoa 3
Hangzhou 3
Kilburn 3
Seoul 3
Verona 3
Amadora 2
Chicago 2
Des Moines 2
Dublin 2
Düsseldorf 2
Edinburgh 2
Fuzhou 2
Helsinki 2
Olomouc 2
Parma 2
Pavia 2
Potomac 2
Redmond 2
Suri 2
Taipei 2
Tappahannock 2
Walnut 2
Wandsworth 2
Abu Dhabi 1
Amsterdam 1
Andover 1
Ardabil 1
Auburn Hills 1
Bologna 1
Bordeaux 1
Brescia 1
Catania 1
Changchun 1
Chateauguay 1
Collegeville 1
Denver 1
Distrito Federal 1
Florence 1
Totale 3.693
Salva come PNG Salva come JPEG
Nome #
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma 130
Inflammatory cells in the bronchial glands of smokers with chronic bronchitis 119
Association between toluene diisocyanate-induced asthma and DQB1 markers: a possible role for aspartic acid at position 57 116
Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma 115
Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation 112
CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease 111
Interleukin-13 and-4 expression in the central airways of smokers with chronic bronchitis 111
The distribution of Neurokinin-1 and Neurokinin-2 receptors in human central airways 103
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics 102
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 102
Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis 98
Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study 98
Enfisema polmonare: prospettive di terapia 97
Three-Year Hospitalization and Mortality in Elderly Smokers with Chronic Obstructive Pulmonary Disease or Chronic Heart Failure 96
Helicobacter pylori and chronic bronchitis. 95
Integrin expression on neutrophils and mononuclear cells in blood and induced sputum in stable asthma 92
Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease 89
Inhaled corticosteroids in COPD: Friend or foe? 89
CD-4-positive T-lymphocytes infiltrate the bronchial mucosa of patients with Sjogren's syndrome 87
What can we learn from late-onset and occupational asthma? 84
Asthma progression and mortality: The role of inhaled corticosteroids 84
INCREASED BRONCHIAL RESPONSIVENESS IN PRIMARY SJOGRENS-SYNDROME - A SIGN OF TRACHEOBRONCHIAL INVOLVEMENT 82
Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC 81
Severity of airflow limitation is associated with severity of airway inflammation in smokers 81
Increased bronchial responsiveness in primary and secondary Sjogren's syndrome 79
Blood eosinophils for the management of COPD patients? 78
Comparative effectiveness of triple therapy versus dual bronchodilation in COPD 76
Vasoactive intestinal peptide receptors in the airways of smokers with chronic bronchitis 74
Xanthine oxidase in broncho-alveolar lavage fluid of subjects with chronic bronchitis. 73
Increased xanthine oxidase activity in broncoalveolar lavage fluid from subject with chronic bronchitis 72
Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease 70
Similarities between mechanism of superoxide production in ultrasuond treated human serum and in BALF from patients with chronic bronchitis 68
Inhaled corticosteroid containing combinations and mortality in COPD 68
Production of superoxide radicals by bronchoalveolar lavage fluid obteined from patients with chronic bronchitis 67
Oxygen radical production of broncho-alveolar lavage fluid (BALF) from subjects with chronic bronchitis. 67
Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal 67
Sonicated serum damages human lymphocyte DNA: a model of free radicals induced cell injury 65
Substance P and neurokinin-A in induced sputum from patients with chronic obstructive pulmonary disease. 65
Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation 65
Increased oxidant-induced clastogenic activity in bronchoalveolar lavage fluid obtained from subjects with chronic bronchitis. 62
Expression of monocyte chemoattractant protein-1 (MCP-1) and CC chemokine receptor 2 (CCR2B) by purified blood monocytes in smokers with lung cancer. 62
Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA 62
Very low density lipoproteins mediate DNA damage induced by sonicated serum on human lymphocytes. 61
Interleukin-6, but not pentraxin 3, predicts adverse clinical outcomes on short-term prognosis of patients with incipient heart failure 60
Triple therapy for all patients with severe symptomatic COPD at risk of exacerbations 60
Immunization and challenge with toulene diisocyanate decrease tachykinin and calcitonin gene-related peptide immunoreactivity in guinea pig central airways 58
Impact of smoking status and concomitant medications on the effect of high-dose N-acetylcysteine on chronic obstructive pulmonary disease exacerbations: A post-hoc analysis of the PANTHEON study 58
Mucin expression in the bronchiolar epithelium of patients with chronic obstructive pulmonary disease. 57
Significant correlation between interleukin-10 expression and progression of non-small cell lung cancer through heme oxygenase 57
Current controversies in chronic obstructive pulmonary disease: A report from the global initiative for chronic obstructive lung disease scientific committee 57
Human leukocyyte antigen associations in occupational asthma induced by isocyanates 56
Differential expression of heme oxygenase (HO)-1 in macrophages of lung tumour and tumour-free lung tissues 56
Neutrophils and asthma. 54
Mechanism of occupational asthma 54
Chronic obstructive pulmonary disease in heart failure: prevalence, therapeutic and prognostic implications. 54
Cytoplasmic expression of p21 CIPI/WAF1 is increased in endoalveolar macrophages of smokers. 53
Altri problemi di patologia respiratoria 52
Espression of vasoactive intestinal peptide 1 receptor (VIPR1) in the central airways of smokers 52
HLA class II molecules and asthma induced by toleune diisocyanate 51
Glucocorticoidi 50
null 50
Subclinical cardiac dysfunction in moderate to severe chronic obstructive pulmonary disease (COPD) patients 47
Prevention of Chronic Obstructive Pulmonary Disease 47
Management of chronic refractory cough in adults 45
null 45
Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact 33
Small airway dysfunction: not so silent after all? 29
An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal 28
Chronic cough in adults 27
Extrafine beclometasone dipropionate/ formoterol fumarate vs double bronchodilation therapy in patients with copd: A historical real-world non-inferiority study 26
Spirometry: A practical lifespan predictor of global health and chronic respiratory and non-respiratory diseases 20
Rate of Decline of FEV1 as Biomarker of Survival? 19
COPD is a risk factor for squamous cell histotype in smokers who develop nonsmall cell lung cancer. Eur Resp J 2003; 22 Supp.45: 361s. 18
Inhaled long-acting muscarinic antagonists in asthma - A narrative review 17
CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease 14
Influence of asbestos exposure on heme oxygenase(HO)-1 expression in lung tumour-associated macrophages. 169 (7): A411. 14
Development of a tool to detect small airways dysfunction in asthma clinical practice 7
Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study 4
Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting: Best Practice 2
Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS 2
Sex differences in asthma control, lung function and exacerbations: the ATLANTIS study 1
Totale 5.109
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.351
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 699
Totale 26.050
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.125 195 26 69 151 68 131 86 113 83 89 92 22
2020/2021869 55 82 44 64 37 70 30 100 27 104 138 118
2021/2022766 24 51 46 60 60 25 25 43 36 52 68 276
2022/2023602 73 13 39 76 107 80 35 53 70 3 36 17
2023/2024376 41 46 20 13 25 55 12 24 14 5 10 111
2024/202529 29 0 0 0 0 0 0 0 0 0 0 0
Totale 5.109